Cargando…

Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors

BACKGROUND: Although some factors that predict the prognosis in pancreatic neuroendocrine tumor (pNET) have been confirmed, the predictive value of lymph node metastasis (LNM) in the prognosis of pNETs remains conflicting and it is not clear whether regional lymphadenectomy should be performed in al...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zheng, Wang, Fei, Li, Zheng, Ye, Zeng, Zhuo, Qifeng, Xu, Wenyan, Liu, Wensheng, Liu, Mengqi, Fan, Guixiong, Qin, Yi, Zhang, Yue, Chen, Xuemin, Yu, Xianjun, Xu, Xiaowu, Ji, Shunrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088076/
https://www.ncbi.nlm.nih.gov/pubmed/35538535
http://dx.doi.org/10.1186/s12893-022-01595-y
_version_ 1784704291592732672
author Zhang, Zheng
Wang, Fei
Li, Zheng
Ye, Zeng
Zhuo, Qifeng
Xu, Wenyan
Liu, Wensheng
Liu, Mengqi
Fan, Guixiong
Qin, Yi
Zhang, Yue
Chen, Xuemin
Yu, Xianjun
Xu, Xiaowu
Ji, Shunrong
author_facet Zhang, Zheng
Wang, Fei
Li, Zheng
Ye, Zeng
Zhuo, Qifeng
Xu, Wenyan
Liu, Wensheng
Liu, Mengqi
Fan, Guixiong
Qin, Yi
Zhang, Yue
Chen, Xuemin
Yu, Xianjun
Xu, Xiaowu
Ji, Shunrong
author_sort Zhang, Zheng
collection PubMed
description BACKGROUND: Although some factors that predict the prognosis in pancreatic neuroendocrine tumor (pNET) have been confirmed, the predictive value of lymph node metastasis (LNM) in the prognosis of pNETs remains conflicting and it is not clear whether regional lymphadenectomy should be performed in all grades of tumors. METHODS: We included pNET patients undergoing surgery in Shanghai pancreatic cancer institute (SHPCI). The risk factors for survival were investigated by the Kaplan–Meier method and Cox regression model. We evaluated the predictors of LNM using Logistic regression. RESULTS: For 206 patients in the SHPCI series, LNM was an independent prognostic factor for entire cohort suggested by multivariate Cox regression analysis. LNM (P = 0.002) predicted poorer overall survival (OS) in grade 2/3 cohort, but there is no significant association between LNM and OS in grade 1 cohort. Grade (P < 0.001) and size (P = 0.049) predicted LNM in entire cohort. Grade (P = 0.002) predicted LNM while regardless of size in grade 2/3 cohort. CONCLUSIONS: Based on our own retrospective data obtained from a single center series, LNM seems to be associated with poorer outcome for patients with grade 2/3 and/or grade 1 > 4 cm tumors. On the other way, LNM was seems to be not associated with prognosis in patients with grade 1 tumors less than 4 cm. Moreover, tumor grade and tumor size seem to act as independent predictors of LNM. Thus, regional lymphadenectomy should be performed in grade 2/3 patients but was not mandatory in grade 1 tumors < 4 cm. It is reasonable to perform functional sparing surgery for grade 1 patients or propose a clinical-radiological monitoring. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-022-01595-y.
format Online
Article
Text
id pubmed-9088076
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90880762022-05-11 Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors Zhang, Zheng Wang, Fei Li, Zheng Ye, Zeng Zhuo, Qifeng Xu, Wenyan Liu, Wensheng Liu, Mengqi Fan, Guixiong Qin, Yi Zhang, Yue Chen, Xuemin Yu, Xianjun Xu, Xiaowu Ji, Shunrong BMC Surg Research BACKGROUND: Although some factors that predict the prognosis in pancreatic neuroendocrine tumor (pNET) have been confirmed, the predictive value of lymph node metastasis (LNM) in the prognosis of pNETs remains conflicting and it is not clear whether regional lymphadenectomy should be performed in all grades of tumors. METHODS: We included pNET patients undergoing surgery in Shanghai pancreatic cancer institute (SHPCI). The risk factors for survival were investigated by the Kaplan–Meier method and Cox regression model. We evaluated the predictors of LNM using Logistic regression. RESULTS: For 206 patients in the SHPCI series, LNM was an independent prognostic factor for entire cohort suggested by multivariate Cox regression analysis. LNM (P = 0.002) predicted poorer overall survival (OS) in grade 2/3 cohort, but there is no significant association between LNM and OS in grade 1 cohort. Grade (P < 0.001) and size (P = 0.049) predicted LNM in entire cohort. Grade (P = 0.002) predicted LNM while regardless of size in grade 2/3 cohort. CONCLUSIONS: Based on our own retrospective data obtained from a single center series, LNM seems to be associated with poorer outcome for patients with grade 2/3 and/or grade 1 > 4 cm tumors. On the other way, LNM was seems to be not associated with prognosis in patients with grade 1 tumors less than 4 cm. Moreover, tumor grade and tumor size seem to act as independent predictors of LNM. Thus, regional lymphadenectomy should be performed in grade 2/3 patients but was not mandatory in grade 1 tumors < 4 cm. It is reasonable to perform functional sparing surgery for grade 1 patients or propose a clinical-radiological monitoring. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-022-01595-y. BioMed Central 2022-05-10 /pmc/articles/PMC9088076/ /pubmed/35538535 http://dx.doi.org/10.1186/s12893-022-01595-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Zhang, Zheng
Wang, Fei
Li, Zheng
Ye, Zeng
Zhuo, Qifeng
Xu, Wenyan
Liu, Wensheng
Liu, Mengqi
Fan, Guixiong
Qin, Yi
Zhang, Yue
Chen, Xuemin
Yu, Xianjun
Xu, Xiaowu
Ji, Shunrong
Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors
title Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors
title_full Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors
title_fullStr Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors
title_full_unstemmed Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors
title_short Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors
title_sort value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088076/
https://www.ncbi.nlm.nih.gov/pubmed/35538535
http://dx.doi.org/10.1186/s12893-022-01595-y
work_keys_str_mv AT zhangzheng valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT wangfei valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT lizheng valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT yezeng valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT zhuoqifeng valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT xuwenyan valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT liuwensheng valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT liumengqi valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT fanguixiong valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT qinyi valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT zhangyue valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT chenxuemin valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT yuxianjun valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT xuxiaowu valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors
AT jishunrong valueoflymphadenectomyinpatientswithsurgicallyresectedpancreaticneuroendocrinetumors